A non-interventional, fully anonymized study for the comparative evaluation of a new direct detection methods for infection with SARS-CoV-2 (COVID-19) in clinical samples

• Conditions: COVID-19; J12.8; J84.9; Other viral pneumonia; Interstitial pulmonary disease, unspecified

• Registration Number: DRKS00023821
• Lead Sponsor: niversitätsklinikum der RWTH Aachen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-04-30
• Study Start: 2020-12-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 356

Inclusion Criteria

Patients with respiratory symptoms

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Detection of SARS-CoV-2 genome by reverse transcriptase polymerase chain reaction (RT-PCR) (specific signal and ct value) versus LIF (laser-induced fluorescence spectroscopy, detection of a specific fluorescence emission spectrum) in respiratory specimen from patients with clinical symptoms of a respiratory infection.